Macrogenics (MGNX) Receivables (2012 - 2026)

Macrogenics (MGNX) has 15 years of Receivables data on file, last reported at $10.4 million in Q1 2026.

• On a quarterly basis, Receivables fell 1.12% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a 1.12% decrease from a year earlier, with the FY2025 full-year figure at $13.4 million, up 210.35% from the prior year.
• Receivables for Q1 2026 stood at $10.4 million, down from $13.4 million in the prior quarter.
• Over the last five years, Receivables for MGNX reached as high as $69.2 million in Q3 2025 and fell as low as $4.3 million in Q4 2024.
• Historically, Receivables has averaged $19.1 million across 5 years, with a median of $12.5 million in 2025.
• Across the five-year window, Receivables slumped 81.56% in 2023 and surged 691.2% in 2025, its largest moves.
• Year by year, Receivables stood at $56.2 million in 2022, then slumped by 81.56% to $10.4 million in 2023, then tumbled by 58.44% to $4.3 million in 2024, then jumped by 210.35% to $13.4 million in 2025, then dropped by 22.04% to $10.4 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $10.4 million in Q1 2026, $13.4 million in Q4 2025, and $69.2 million in Q3 2025.